Fruitfly biologists have developed some elaborate genetic tricks to express transgenes in a spatially restricted manner. The bipartite GAL4/UAS system exploits the yeast GAL4 transcriptional activator and the upstream activating sequence (UAS) to which it binds to drive transgene expression. In the October 23
They created "GeneSwitch", a GAL4-progesterone-receptor fusion protein that can be regulated by the drug RU486. They tested the ability of the GeneSwitch system to drive pre- or post-synaptic expression at